A world-first study could help revolutionise the treatment of brain cancer, researchers say. The research will trial multiple new treatments for people in the UK living with an aggressive form of ...

This follows a summer of strong demand, with 30.7 million passengers passing through the west London airport’s terminals between June ...

Former Wales international Gloria O’Connell says it would be a proud moment for the country’s female football pioneers should Jess Fishlock and company complete a 50-year journey from “laughing stock” ...

Arnold’s potential move to Real Madrid would rival the signing of Kylian Mbappe, according to former Red Jermaine Pennant.

Public fury has swelled over the degraded state of the country’s rivers, lakes and coastal waters and at a lack of investment in water infrastructure, rising bills, high dividends and debt and ...

The Siamese crocodile was thought to have been hunted to extinction – until a survey revealed a tiny population in the wild.

Care home staff in South Cumbria have been trained to deliver Covid-19 and flu jabs to residents. This is part of an effort by NHS staff in the North West, who have managed to deliver more than one ...

The rider of the motorbike a man in his 50s was seriously injured and taken to Furness Hospital to have those injures assessed.

Health Secretary Wes Streeting is to vote against an assisted dying Bill amid fears around coercion and people feeling a “duty to die”. The Cabinet minister had previously said he was ...

A retired journalist who took part in the clinical trial for the new Alzheimer’s drug has described how he feels “as normal as a 78-year-old can be”. Peter Almond finished a trial for donanemab in ...

A new Alzheimer’s drug has been rejected for widespread use in the health service in England after the health spending watchdog said it “does not currently demonstrate value for the NHS”. The news ...

Donanemab is a targeted antibody drug which slows down the early stages of Alzheimer’s. The drug, and another new drug for Alzheimer’s called lecanemab, have been billed as a huge step forward in ...